Login / Signup
Metastatic small cell neuroendocrine carcinoma of the cervix treated with the PD-1 inhibitor, nivolumab: a case report.
Sarah E Paraghamian
Teresa C Longoria
Ramez N Eskander
Published in:
Gynecologic oncology research and practice (2017)
Immune checkpoint inhibitors may be active in neuroendocrine cervical cancer, with potential for dramatic responses in a modest subset of patients.
Keyphrases
</>
end stage renal disease
newly diagnosed
squamous cell carcinoma
ejection fraction
small cell lung cancer
single cell
prognostic factors
peritoneal dialysis
patient reported outcomes
preterm birth
bone marrow
mesenchymal stem cells